2Taha Y, Raab Y, Larsson A, et al. Vascular endothelial growth factor (VEGF)-a possible mediator of inflammation and mucosal permeability in patients with collagenous colitis [J]. Dig Dis Sci, 2004 Jan, 49(1): 109.
3Pousa I D, Gisbert J P, Mate J. Vascular development in inflarnmatory bowel disease [ J ]. Gastroenterol Hepatol, 2006 Aug-Sep, 29(7): 414.
4WierrWiercinska-Drapalo A, Jaroszewicz J, Parfieniuk A, et al. Pigment epithelium-derived factor in ulcerative colitis: possible relationship with disease activity[J ]. Regul Pept, 2007 Apr 5, 140(1-2): 1-4. Epub 2006 Dec 22.
5Ferrante M, Pierik M, Henckaerts L. The role of vascular endothelial growth factor (VEGF) in inflammatory bowel disease [J]. Inflamm Bowel Dis, 2006 Sep, 12(9) : 870.
8Ramos MA, Kuzuya M, Esaki T, et al. Induction of macrophage VEGF in response to oxidized LDL and VEGF accumulation in human atherosclerosis lesions [ J ]. Arter Thromb Vasc Biol,1998, 18(7) : 188-196.
9Jialal I, Devara JS. The role of oxidized low density lipoprotein in atherogenesis [ J ]. Nutrition, 1996, 126 ( 8 ) : 1053- 1057.
10Moulton KS, Heller E, Konerding MA, et al. Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice[ J ]. Circulation , 1999,14 : 1726-1732.
